As U.S. birth rate falls, Trump officials downplay contraception in family planning program

TL;DR

US birth rates continue to fall, with a 1% decline in 2025 and fertility rates down significantly since 2007.
The Trump administration is overhauling Title X, a program historically focused on contraception and reproductive healthcare for low-income women.
The new funding notice for Title X shifts emphasis to fertility, family formation, and conditions like endometriosis, while describing contraception as overprescribed.
Experts like demographer Alison Gemmill and economist Phillip Levine attribute declining birth rates to delayed adult milestones and planned childbearing, not lack of contraception access.
Critics argue the Title X overhaul represents a 'Trojan horse' for a different agenda and could restrict access to essential reproductive healthcare services.
Supporters, such as Emma Waters of The Heritage Foundation, view the changes as overdue attention to women's health issues and an empowerment of women's fertility awareness.
The article highlights a contradiction where Title X prioritizes diagnosing conditions like endometriosis while deemphasizing pharmaceutical treatments recommended by medical professionals.
Concerns are raised about potential consequences, including increased demand for abortion care, higher maternal mortality rates, and reduced access to contraception for millions of individuals.
Previous regulatory changes under the Trump administration led to a significant drop in Title X participation.

Continuar leyendo el artículo original